Haining R

No ORCID on file · 3 papers in corpus · active 1989-1992

Study types

  • article 3

Condition tags

  • endometriosis 3
article 1992
Long‐acting gonadotrophin releasing hormone agonist implant causes variable duration of suppression of ovarian steroid and inhibin secretion
Clinical endocrinology ·doi:10.1111/j.1365-2265.1992.tb02908.x

OBJECTIVE: The duration of action of a gonadotrophin releasing hormone (GnRH) agonist implant designed to be effective for 3 months was investigated in women by monitoring drug release and ovarian hormone secretion. Serum inhibin secretion …

article 1990
Long-term suppression of ovarian function by a luteinizing-hormone releasing hormone agonist implant in patients with endometriosis
Fertility and Sterility ·doi:10.1016/s0015-0282(16)53217-8

Ten endometriosis patients received luteinizing hormone releasing hormone (LH-RH) agonist (buserelin) implant injections (6.6 mg subcutaneously) at days 0, 42, 84 and 126. Serum LH and follicle-stimulating hormone (FSH) were lowered by day …

article 1989
No HLA‐DR specificity is associated with endometriosis
Tissue antigens ·doi:10.1111/j.1399-0039.1989.tb01729.x

Thirty-one patients with endometriosis were typed for HLA-A, B and DR antigens. No association was found between the disease and any DR specificity, which may be taken as evidence against an autoimmune aetiology.